Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: HSBC Cuts Shell Buts Raises Next

Fri, 01st May 2020 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

----------

FTSE 100

----------

HSBC CUTS SHELL TO 'HOLD' (BUY)

----------

GOLDMAN SACHS CUTS SHELL B PRICE TARGET TO 1850 (2000) PENCE - 'BUY'

----------

BERENBERG CUTS SHELL B TO 'HOLD' (BUY) - PRICE TARGET 1440 (1450) PENCE

----------

HSBC RAISES NEXT TO 'BUY' ('HOLD') - TARGET 5570 (7050) PENCE

----------

UBS RAISES WHITBREAD TO 'BUY' ('NEUTRAL') - TARGET 3610 (4875) PENCE

----------

LIBERUM CUTS HARGREAVES LANSDOWN TO 'HOLD' ('BUY') - TARGET 1540 (2075) PENCE

----------

BARCLAYS RAISES ST JAMES'S PLACE TARGET TO 1118 (1098) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 9200 (9000) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 5900 (5860) PENCE - 'HOLD'

----------

BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 7900 (6900) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES RECKITT BENCKISER PRICE TARGET TO 7450 (7350) PENCE - 'BUY'

----------

HSBC RAISES RECKITT BENCKISER PRICE TARGET TO 7300 (7000) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FERGUSON PRICE TARGET TO 6600 (5900) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BAE SYSTEMS PRICE TARGET TO 695 (730) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS SHELL PRICE TARGET TO 1700 (1900) PENCE - 'OUTPERFORM'

----------

UBS CUTS INTERCONTINENTAL HOTELS PRICE TARGET TO 3900 (4150) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES BARCLAYS PRICE TARGET TO 160 (150) PENCE - 'BUY'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 9500 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 165 (180) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES SHELL PRICE TARGET TO 1150 (1140) PENCE - 'HOLD'

----------

RBC RAISES SHELL B PRICE TARGET TO 1800 (1700) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES RECKITT BENCKISER PRICE TARGET TO 6300 (5950) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS INTERNATIONAL CONSOLIDATED AIRLINES TO 'NEUTRAL' (BUY) - PRICE TARGET 250 (500) PENCE

----------

CREDIT SUISSE RAISES RECKITT BENCKISER PRICE TARGET TO 6100 (5900) PENCE - 'NEUTRAL'

----------

DZ BANK RAISES FAIR VALUE FOR RECKITT BENCKISER TO 7100 (6500) PENCE - 'BUY'

----------

DZ BANK RAISES FAIR VALUE FOR GLAXOSMITHKLINE TO 1950 (1900) PENCE - 'BUY'

----------

RBC RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4600) PENCE - 'UNDERPERFORM'

----------

DZ BANK RAISES FAIR VALUE FOR ASTRAZENECA TO 7300 (6500) PENCE - 'SELL'

----------

RBC CUTS RSA INSURANCE PRICE TARGET TO 550 (600) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES ASHTEAD GROUP TARGET TO 2500 (2050) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

BARCLAYS CUTS JOHN LAING PRICE TARGET TO 425 (440) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM CUTS RATHBONE BROTHERS PRICE TARGET TO 1520 (2100) PENCE - 'HOLD'

----------

LIBERUM RAISES INTEGRAFIN PRICE TARGET TO 455 (435) PENCE - 'HOLD'

----------

LIBERUM CUTS QUILTER PRICE TARGET TO 145 (185) PENCE - 'BUY'

----------

LIBERUM CUTS BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 330 (384) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS IMI PRICE TARGET TO 800 (950) PENCE - 'UNDERPERFORM'

----------

JPMORGAN RAISES CONVATEC PRICE TARGET TO 167 (160) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 380 (400) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES SYNTHOMER PRICE TARGET TO 330 (260) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES CONVATEC PRICE TARGET TO 180 (175) PENCE - 'UNDERPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG INITIATES AB DYNAMICS WITH 'BUY' - TARGET 2050 PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.